Experimental and Clinical Psychopharmacology (ESP)

Experimental and Clinical Psychopharmacology ® publishes advances in translational and interdisciplinary research on psychopharmacology, broadly defined, and/or substance abuse. The scope of research in these areas continues to expand and to benefit from collaborations across a broad range of disciplines, including behavioral science, biochemistry, brain imaging, genetics, medicine, neuroendocrinology, neuroscience, and pharmacology. The overall goal of Experimental and Clinical Psychopharmacology is to provide a forum for high-quality, innovative preclinical and clinical research that advances our understanding of the behavioral and biological determinants of the effects of centrally acting drugs. The journal publishes original reports and brief communications on the development and evaluation of pharmacotherapies for a range of mental health diagnoses, the influence of genetics and hormones on responses to psychoactive drugs, the pharmacological management of pain, and brain imaging studies of the neural correlates of psychoactive drug effects.

Experimental and Clinical Psychopharmacology (ESP) is :-

• International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Pharmaceutics, Psychiatry and Mental Health , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1064-1297, E-ISSN: 1936-2293, Established: 1993, Impact Factor: 3.4
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE